UPDATE : Monday, September 7, 2020
상단여백
SK Chemical to co-promote Janssen’s dementia treatment by Lee Han-soo 2019-02-12 15:55
Direct-to-consumer genetic testing allowed for Parkinson’s, lung cancer by Park Gi-taek 2019-02-12 14:48
Demands for MMR vaccines spike amid resurgence of measles by Park Gi-taek 2019-02-12 11:19
US pharma group asks USTR to designate Korea as priority foreign country by Lee Han-soo 2019-02-11 17:49
IVI to cooperate with CEPI to develop vaccines by Lee Han-soo 2019-02-11 16:41
라인
Gilead’s hepatitis B drug posts disappointing sales in 2018 by Kim Yun-mi 2019-02-11 15:29
‘Lung function bigger factor than obesity in metabolic health’ by Lee Han-soo 2019-02-11 15:28
Sales of antidiabetic SGLT-2 inhibitors expand 40% in 2018 by Kim Yun-mi 2019-02-11 14:35
SMC introduces vNOTES surgery by Lee Han-soo 2019-02-11 13:20
Samsung Bioepis, C-Bridge Capital to develop biosimilars in China by Lee Han-soo 2019-02-11 11:23
라인
Novo Nordisk has high expectations for GLP-1 receptor agonists by Kim Yun-mi 2019-02-08 17:11
Bioneer’s HIV diagnostic kit registered on Global Fund’s purchase list by Park Gi-taek 2019-02-08 16:46
‘Total homocysteine increases risk of cerebral infarction’ by Lee Han-soo 2019-02-08 16:13
Pangen wins Malaysia’s nod for epoetin alfa biosimilar by Lee Han-soo 2019-02-08 16:13
Sanofi seeks to add cholesterol-lowering drug’s new indication in Korea by Kim Yun-mi 2019-02-08 16:12
라인
Multinationals prepare next-generation pneumococcal vaccines by Kim Yun-mi 2019-02-08 12:02
Kainos Medicine starts developing treatment for multiple system atrophy by Lee Han-soo 2019-02-08 11:47
‘Novartis’ Cosentyx, a cost-effective alternative to Humira’ by Lee Han-soo 2019-02-07 17:14
Seoul accepts Bayer’s request to reduce study subjects of cancer drug by Lee Hye-seon 2019-02-07 16:06
FDA starts inspecting SK Biopharm’s epilepsy treatment by Lee Han-soo 2019-02-07 16:01
여백
여백
여백
Back to Top